| BAFNBayFirst Financial Corp. |
n/d |
n/d |
2025 |
| BAMXFBayerische Motoren Werke AG |
n/d |
n/d |
n/d |
| BLIVBeLive Holdings |
SGD 1,8 mi |
-297,8% |
2024 |
| ONCBeOne Medicines Ltd. |
US$ 5,3 bi |
5,4% |
2025 |
| BODIBeachbody Company, Inc. |
US$ 251,7 mi |
-1,1% |
2025 |
| BBTBeacon Financial Corp |
US$ 29,9 mi |
301,4% |
2025 |
| BEEMBeam Global |
US$ 28,2 mi |
-95,6% |
2025 |
| BEAMBeam Therapeutics Inc. |
US$ 139,7 mi |
-57,2% |
2025 |
| BMRBeamr Imaging Ltd. |
US$ 3,1 mi |
-194,6% |
2025 |
| BLNEBeeline Holdings, Inc. |
US$ 7,8 mi |
-298,2% |
2025 |
| OZBelpointe PREP, LLC |
US$ 9,2 mi |
-435,9% |
2025 |
| BSPBending Spoons S.p.A. |
n/d |
n/d |
n/d |
| BENFBeneficient |
-US$ 39,1 mi |
n/d |
2026 |
| BNTCBenitec Biopharma Inc. |
n/d |
n/d |
2026 |
| BNIGFBeroni Group Ltd |
n/d |
n/d |
n/d |
| TACOBerto Acquisition Corp. |
n/d |
n/d |
2025 |
| GUACBerto Acquisition Corp. II |
n/d |
n/d |
n/d |
| BSPKBespoke Extracts, Inc. |
US$ 1,1 mi |
-92,8% |
2024 |
| BGFRBestGofer Inc. |
US$ 5,3 mil |
-489,5% |
2025 |
| BBNXBeta Bionics, Inc. |
US$ 100,3 mi |
-73,0% |
2025 |
| BETRBetter Home & Finance Holding Co |
US$ 164,9 mi |
-100,6% |
2025 |
| BETRFBetterLife Pharma Inc. |
n/d |
n/d |
2018 |
| XAIRBeyond Air, Inc. |
US$ 7,7 mi |
-433,0% |
2026 |
| BYSIBeyondSpring Inc. |
US$ 0 |
n/d |
2025 |
| BCAXBicara Therapeutics Inc. |
n/d |
n/d |
2025 |
| BGDEBig Digital Energy, Inc. |
US$ 39,8 mi |
-59,5% |
2025 |
| DSYBig Tree Cloud Holdings Ltd |
US$ 2,6 mi |
-1.272,1% |
2025 |
| BBAIBigBear.ai Holdings, Inc. |
US$ 127,7 mi |
-230,2% |
2025 |
| BHBiglari Holdings Inc. |
US$ 395,3 mi |
-9,5% |
2025 |
| BILIBilibili Inc. |
US$ 4,3 bi |
3,9% |
2025 |
| BLLNBillionToOne, Inc. |
US$ 305,1 mi |
2,4% |
2025 |
| BESSBimergen Energy Corp |
n/d |
n/d |
2025 |
| BCGBinah Capital Group, Inc. |
US$ 187,1 mi |
1,2% |
2025 |
| FLXBingEx Ltd |
US$ 570,9 mi |
2,7% |
2025 |
| BIOEBio Essence Corp |
US$ 1,9 mi |
47,2% |
2025 |
| BGMSBio Green Med Solution, Inc. |
US$ 747 mil |
-401,3% |
2025 |
| BIOABioAge Labs, Inc. |
US$ 9 mi |
-896,1% |
2025 |
| BCABBioAtla, Inc. |
n/d |
n/d |
2025 |
| BCDABioCardia, Inc. |
US$ 0 |
n/d |
2025 |
| BICXBioCorRx Inc. |
US$ 797,2 mil |
-431,5% |
2025 |
| BLRXBioLineRx Ltd. |
US$ 1,2 mi |
-171,7% |
2025 |
| BNTXBioNTech SE |
€ 2,9 bi |
-39,6% |
2025 |
| BGLCBioNexus Gene Lab Corp |
US$ 7,4 mi |
-40,2% |
2025 |
| BRTXBioRestorative Therapies, Inc. |
US$ 359,7 mil |
-3.959,4% |
2025 |
| BHICBioScience Health Innovations, Inc. |
US$ 5,7 mi |
11,3% |
2025 |
| BSEMBioStem Technologies, Inc. |
n/d |
n/d |
n/d |
| BTAIBioXcel Therapeutics, Inc. |
US$ 642 mil |
-10.887,4% |
2025 |
| BIOXBioceres Crop Solutions Corp. |
US$ 335,1 mi |
-16,5% |
2025 |
| BDRXBiodexa Pharmaceuticals Plc |
n/d |
n/d |
n/d |
| BFRIBiofrontera Inc. |
US$ 41,7 mi |
-25,3% |
2025 |